Posted on 7 November 20247 November 2024 After Lilly’s GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy Following Eli Lilly's disappointing earnings showing last week, Novo Nordisk’s latest report on the performance of its GLP-1 sta...